{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T18:05:22Z","timestamp":1775066722215,"version":"3.50.1"},"reference-count":41,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["23-15-00456"],"award-info":[{"award-number":["23-15-00456"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>The main goal of this study was to characterize cancer\/testis antigens (CTAs) as potential molecular markers of ovarian cancer. First, we gathered and analyzed a significantly large dataset of 21 selected CTAs that are encoded by 32 genes; the dataset consisted of the mutation data, expression data, and survival data of patients with ovarian cancer (n = 15,665). The 19 functionally significant missense mutations were identified in 9 CTA genes: ACRBP, CCT4, KDM5B, MAGEA1, MAGEA4, PIWIL1, PIWIL2, PRAME, and SPA17. The analysis of the mRNA expression levels of 21 CTAs in healthy and tumor ovarian tissue showed an up-regulation in the expression level of AKAP3, MAGEA4, PIWIL1, and PRAME in tumor samples and a down-regulation in the expression level of CTAG1A, CTAG1B, MAGEC1, and PIWIL2. The CCT4 up-regulation and PRAME mutations were correlated with a good prognosis for ovarian cancer, while higher levels of GAGE2A and CT45A1 mRNAs were correlated with a poor prognosis for ovarian cancer patients. Thus, GAGE2, CT45, CCT4, and PRAME cancer\/testis antigens can be considered as potential prognostic markers for ovarian tumors, and GAGE2, CCT4, and PRAME were revealed to be correlated with the prognosis for ovarian cancer patients for the first time.<\/jats:p>","DOI":"10.3390\/diagnostics13193092","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T05:48:13Z","timestamp":1695966493000},"page":"3092","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Characterization of Cancer\/Testis Antigens as Prognostic Markers of Ovarian Cancer"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0082-6833","authenticated-orcid":false,"given":"Ramilia","family":"Vlasenkova","sequence":"first","affiliation":[{"name":"Biomarker Research Laboratory, Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daliya","family":"Konysheva","sequence":"additional","affiliation":[{"name":"Biomarker Research Laboratory, Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alsina","family":"Nurgalieva","sequence":"additional","affiliation":[{"name":"Biomarker Research Laboratory, Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramziya","family":"Kiyamova","sequence":"additional","affiliation":[{"name":"Biomarker Research Laboratory, Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1002\/cncr.26025","article-title":"Early Detection of Ovarian Cancer: If Only We Had a \u201cPap Smear\u201d for This Disease","volume":"117","author":"Bell","year":"2011","journal-title":"Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-018-0475-z","article-title":"Cancer-Testis Antigens in Ovarian Cancer: Implication for Biomarkers and Therapeutic Targets","volume":"12","author":"Xie","year":"2019","journal-title":"J. Ovarian Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-pharmtox-011112-140326","article-title":"Cause and Consequence of Cancer\/Testis Antigen Activation in Cancer","volume":"54","author":"Whitehurst","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"D816","DOI":"10.1093\/nar\/gkn673","article-title":"CTdatabase: A Knowledge-Base of High-Throughput and Curated Data on Cancer-Testis Antigens","volume":"37","author":"Almeida","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1111\/j.1349-7006.2009.01303.x","article-title":"Cancer\/Testis (CT) Antigens: Potential Targets for Immunotherapy","volume":"100","author":"Caballero","year":"2009","journal-title":"Cancer Sci."},{"key":"ref_7","first-page":"681","article-title":"The expression of cancer-testis antigen in ovarian cancer and the development of immunotherapy","volume":"12","author":"Zhao","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"ref_8","first-page":"1268","article-title":"NY-ESO-1 as a Diagnostic and Prognostic Marker for Myxoid Liposarcoma","volume":"14","author":"Jo","year":"2022","journal-title":"Am. J. Transl. Res."},{"key":"ref_9","first-page":"107","article-title":"The Potential of the CMB305 Vaccine Regimen to Target NY-ESO-1 and Improve Outcomes for Synovial Sarcoma and Myxoid\/Round Cell Liposarcoma Patients. Expert Rev","volume":"17","author":"Pollack","year":"2018","journal-title":"Vaccines"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e28132","DOI":"10.4161\/onci.28132","article-title":"Detection of Cancer\/Testis Antigens as a Diagnostic Tool in Routine Pathology Practice","volume":"3","author":"Chen","year":"2014","journal-title":"Oncoimmunology"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Yang, P., Meng, M., and Zhou, Q. (2021). Oncogenic Cancer\/Testis Antigens Are a Hallmarker of Cancer and a Sensible Target for Cancer Immunotherapy. Biochim. Biophys. Acta (BBA)-Rev. Cancer, 1876.","DOI":"10.1016\/j.bbcan.2021.188558"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The CBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"AACR Project Genie Consortium, AACR Project GENIE Consortium, Andr\u00e9, F., Arnedos, M., Baras, A.S., Baselga, J., Bedard, P.L., Berger, M.F., Bierkens, M., and Calvo, F. (2017). AACR Project GENIE: Powering Precision Medicine through an International Consortium. Cancer Discov., 7, 818\u2013831.","DOI":"10.1158\/2159-8290.CD-17-0151"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature08987","article-title":"International Network of Cancer Genome Projects","volume":"464","author":"Hudson","year":"2010","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"D711","DOI":"10.1093\/nar\/gky964","article-title":"ArrayExpress Update\u2014From Bulk to Single-Cell Expression Data","volume":"47","author":"Athar","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Torrente, A., Lukk, M., Xue, V., Parkinson, H., Rung, J., and Brazma, A. (2016). Identification of Cancer Related Genes Using a Comprehensive Map of Human Gene Expression. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0157484"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Choi, Y., Sims, G.E., Murphy, S., Miller, J.R., and Chan, A.P. (2012). Predicting the Functional Effect of Amino Acid Substitutions and Indels. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046688"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"W452","DOI":"10.1093\/nar\/gks539","article-title":"SIFT Web Server: Predicting Effects of Amino Acid Substitutions on Proteins","volume":"40","author":"Sim","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A Method and Server for Predicting Damaging Missense Mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"D377","DOI":"10.1093\/nar\/gks1118","article-title":"PANTHER in 2013: Modeling the Evolution of Gene Function, and Other Gene Attributes, in the Context of Phylogenetic Trees","volume":"41","author":"Mi","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/humu.22225","article-title":"Predicting the Functional, Molecular, and Phenotypic Consequences of Amino Acid Substitutions Using Hidden Markov Models","volume":"34","author":"Shihab","year":"2013","journal-title":"Hum. Mutat."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"MutationTaster Evaluates Disease-Causing Potential of Sequence Alterations","volume":"7","author":"Schwarz","year":"2010","journal-title":"Nat. Methods"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1093\/nar\/gkr407","article-title":"Predicting the Functional Impact of Protein Mutations: Application to Cancer Genomics","volume":"39","author":"Reva","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"D265","DOI":"10.1093\/nar\/gkz991","article-title":"CDD\/SPARCLE: The Conserved Domain Database in 2020","volume":"48","author":"Lu","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_26","unstructured":"Pedersen, T. (2022, May 16). Tidygraph: A Tidy API for Graph Manipulation. Available online: https:\/\/github.com\/thomasp85\/tidygraph."},{"key":"ref_27","unstructured":"Pedersen, T. (2022, May 16). Ggraph: An Implementation of Grammar of Graphics for Graphs and Networks. Available online: https:\/\/github.com\/thomasp85\/ggraph."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ishihara, M., Kageyama, S., Miyahara, Y., Ishikawa, T., Ueda, S., Soga, N., Naota, H., Mukai, K., Harada, N., and Ikeda, H. (2020). MAGE-A4, NY-ESO-1 and SAGE MRNA Expression Rates and Co-Expression Relationships in Solid Tumours. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-07098-4"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ygyno.2005.06.006","article-title":"A-Kinase Anchoring Protein 3 Messenger RNA Expression Correlates with Poor Prognosis in Epithelial Ovarian Cancer","volume":"99","author":"Sharma","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Daudi, S., Eng, K.H., Mhawech-Fauceglia, P., Morrison, C., Miliotto, A., Beck, A., Matsuzaki, J., Tsuji, T., Groman, A., and Gnjatic, S. (2014). Expression and Immune Responses to MAGE Antigens Predict Survival in Epithelial Ovarian Cancer. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0104099"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lim, S.L., Ricciardelli, C., Oehler, M.K., De Arao Tan, I.M.D., Russell, D., and Gr\u00fctzner, F. (2014). Overexpression of PiRNA Pathway Genes in Epithelial Ovarian Cancer. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0099687"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1097\/PAS.0000000000001944","article-title":"PRAME Expression in Cancer. A Systematic Immunohistochemical Study of >5800 Epithelial and Nonepithelial Tumors","volume":"46","author":"Kaczorowski","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cell.2018.08.065","article-title":"Multi-Level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer","volume":"175","author":"Coscia","year":"2018","journal-title":"Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1080\/15592294.2015.1062206","article-title":"DNA Hypomethylation-Mediated Activation of Cancer\/Testis Antigen 45 (CT45) Genes Is Associated with Disease Progression and Reduced Survival in Epithelial Ovarian Cancer","volume":"10","author":"Zhang","year":"2015","journal-title":"Epigenetics"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature23891","article-title":"Epigenetic Restriction of Extraembryonic Lineages Mirrors the Somatic Transition to Cancer","volume":"549","author":"Smith","year":"2017","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.trecan.2018.08.005","article-title":"Emerging Contributions of Cancer\/Testis Antigens to Neoplastic Behaviors","volume":"4","author":"Gibbs","year":"2018","journal-title":"Trends Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"92966","DOI":"10.18632\/oncotarget.21715","article-title":"Genome-Wide Identification of Cancer\/Testis Genes and Their Association with Prognosis in a Pan-Cancer Analysis","volume":"8","author":"Fonseca","year":"2017","journal-title":"Oncotarget"},{"key":"ref_38","first-page":"3982","article-title":"Myeloid-Derived Suppressor Cells Infiltration in Non-Small-Cell Lung Cancer Tumor and MAGE-A4 and NY-ESO-1 Expression","volume":"19","author":"Hou","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cca.2019.11.032","article-title":"Diagnostic and Prognostic Value of the Cancer-Testis Antigen Lactate Dehydrogenase C4 in Breast Cancer","volume":"503","author":"Cui","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/tan.12113","article-title":"Preferential Expression of Cancer\/Testis Genes in Cancer Stem-like Cells: Proposal of a Novel Sub-Category, Cancer\/Testis\/Stem Gene","volume":"81","author":"Yamada","year":"2013","journal-title":"Tissue Antigens"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1515\/med-2020-0114","article-title":"CCTs as New Biomarkers for the Prognosis of Head and Neck Squamous Cancer","volume":"15","author":"Dong","year":"2020","journal-title":"Open Med."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/19\/3092\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:01:48Z","timestamp":1760130108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/19\/3092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":41,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["diagnostics13193092"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13193092","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]}}}